Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment-Reference-Cited by-同舟云学术

Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment

Published:2008-03 Issue:3 Volume:110 Page:222-226
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Andreadou Elisabeth,Kapaki Elisabeth,Kokotis Panagiotis,Paraskevas George P.,Katsaros Nikolaos,Libitaki Georgia,Zis Vassilios,Sfagos Constantinos,Vassilopoulos Demetrios

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Surgery

Reference31 articles.

1. Abnormal glutamate metabolism in amyotrophic lateral sclerosis;Plaitakis;Ann Neurol,1987

2. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis;Plaitakis;Ann Neurol,1990

3. Serum bilirubin concentration in patients with amyotrophic lateral sclerosis;Iłżecka;Clin Neurol Neurosurg,2003

4. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis;Van Den Bosch;Biochim Biophys Acta,2006

5. Selective loss of glial glutamate transport GLT-1 in amyotrophic lateral sclerosis;Rothstein;Ann Neurol,1995

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Communication defects with astroglia contribute to early impairments in the motor cortex plasticity of SOD1G93A mice;Neurobiology of Disease;2024-04

2. How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?;Brain;2024-02-26

3. Metabolome-wide association study on physical activity;Scientific Reports;2023-02-09

4. Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis;Genes;2023-01-27

5. Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases;Metabolites;2022-09-14